- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03716544
Efficacy of Amplification With Hearing Aids for Tinnitus Relief
March 1, 2024 updated by: KAM Chi Shan Anna, Education University of Hong Kong
Efficacy of Amplification With Hearing Aids for Tinnitus Relief: a Randomized Controlled Trial
This study evaluates the treatment efficacy of tinnitus in people with mild hearing loss.
One-third of participants will use hearing aid, one-third of participants will use customized music, while the other one-third participants will receive no treatment (waiting list control).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Acoustic stimulation could induce plastic changes in the auditory cortex, and tinnitus mechanisms have been viewed as a negative consequence of neural plasticity in the central nervous system after peripheral aggression.
Cortical changes (neural activity in the deafferented cortical area was reduced but the adjacent frequencies of the hearing loss region activated more extensive cortical areas) occur after sensorineural hearing loss, while exposure to an acoustically enriched environment or using hearing aids may minimize or reverse the plastic tonotopic map changes in the auditory cortex.
The use of hearing aids in tinnitus management for people with significant hearing loss will always be associated with an improvement in hearing handicap and quality of life, and that complicates the interpretation of how much hearing aids specifically affect tinnitus.
Thus studies on tinnitus patients with mild hearing loss could be illuminating, and this population will be targeted in the present study.
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hong Kong, Hong Kong
- The Education University of Hong Kong
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18 years old or above
- can provide written informed consent
- have a diagnosis of subjective tinnitus, i.e., the tinnitus can only be heard by the patient and there is no acoustic source
- a tinnitus duration of more than one year
- have pure-tone average between 20 and 40 dB HL
- have bilateral symmetrical hearing loss (i.e. difference less than 15 dB)
- have at least a medium level of distress caused by tinnitus as indicated with total scores above 30 on the TQ-CH
- are committed to complete the 12-month follow-up
Exclusion Criteria:
- objective tinnitus, i.e. tinnitus produced by an internal acoustic source activating the cochlea and can be heard by another person
- received other forms of tinnitus treatments within three months before the baseline assessment session
- any history suggestive of psychiatric illness
- psychological distress or depression as indicated with total scores at or above 15 on the Cantonese HADS
- current hearing aid users
- inability to complete the study as revealed by the medical reports
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Waiting list control group
There will be no treatment for 12 months.
|
|
Experimental: Hearing aid group
Participants will receive amplification with hearing aids.
Bilateral open-fit hearing aids will be fitted.
Participants will be required to use the hearing aids for at least 2 hours daily for 12 months.
|
Use of hearing aids
Other Names:
|
Active Comparator: Customized music group
Customized music according to participants hearing level will be made available in an iPod.
The iPod will deliver ear-specific therapeutic sound for asymmetrical hearing profile.
Participants will have to listen to the therapeutic sound at a comfortable volume for two hours daily for 12 months.
|
Customized music delivered via an iPod
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Tinnitus Functional Index (Chinese version) (TFI-CH)
Time Frame: Change from baseline value at 3 months, 6 months and 12 months after the first day of treatment will be measured.
|
TFI-CH is a 25-item self-administered questionnaire which assesses eight domains of tinnitus impact: intrusiveness; sense of control; cognitive; sleep; auditory; relaxation; quality of life (QoL); emotion.
The total TFI score ranges 0 - 100, the higher score is indicative of greater problem with tinnitus.
|
Change from baseline value at 3 months, 6 months and 12 months after the first day of treatment will be measured.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Tinnitus Questionnaire (Chinese version) (TQ-CH) scores
Time Frame: Change from baseline value at 3 months, 6 months and 12 months after the first day of treatment will be measured.
|
The TQ-CH is a 52-item questionnaire which assesses five dimensions of tinnitus complaint: emotional distress; auditory perceptual difficulties; intrusiveness; sleep disturbance; and somatic complaints.
The total TQ score ranges 0 - 104, the higher score is indicative of greater problem with tinnitus.
|
Change from baseline value at 3 months, 6 months and 12 months after the first day of treatment will be measured.
|
The Tinnitus Handicap Inventory (Chinese version) (THI-CH) scores
Time Frame: Change from baseline value at 3 months, 6 months and 12 months after the first day of treatment will be measured.
|
The THI-CH is a reliable 25-item self-administered Chinese QoL tool that quantifies the impact of tinnitus on daily living.
The total THI score ranges 0 - 100, the higher score is indicative of greater tinnitus handicap.
|
Change from baseline value at 3 months, 6 months and 12 months after the first day of treatment will be measured.
|
Self-rated Visual Analogue Scale (VAS) on tinnitus loudness
Time Frame: Change from baseline value at 3 months, 6 months and 12 months after the first day of treatment will be measured.
|
The subjects will be asked to rate the perceived loudness of their tinnitus on VAS, with "inaudible" (scale rating value = 0) and "very loud" (scale rating value = 100) as reference points for the ends of the scale.
The higher rating is indicative of louder tinnitus.
|
Change from baseline value at 3 months, 6 months and 12 months after the first day of treatment will be measured.
|
Tinnitus loudness matches at the tinnitus frequency and at 1000 Hz
Time Frame: Change from baseline values at 3 months, 6 months and 12 months after the first day of treatment will be measured.
|
Tinnitus loudness matches will be done according to Vernon and Meikle's procedure
|
Change from baseline values at 3 months, 6 months and 12 months after the first day of treatment will be measured.
|
The Chinese Hospital Anxiety and Depression Scale (HADS)
Time Frame: Change from baseline value at 3 months, 6 months and 12 months after the first day of treatment will be measured.
|
The Chinese HADS is a 14-item questionnaire that consists of two subscales that measure anxiety and depression.
It serves as an outcome measure targeting psychological and mental health effects.
|
Change from baseline value at 3 months, 6 months and 12 months after the first day of treatment will be measured.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Anna CS KAM, AuD, The Education University of Hong Kong
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2018
Primary Completion (Actual)
December 31, 2023
Study Completion (Actual)
December 31, 2023
Study Registration Dates
First Submitted
October 17, 2018
First Submitted That Met QC Criteria
October 19, 2018
First Posted (Actual)
October 23, 2018
Study Record Updates
Last Update Posted (Estimated)
March 4, 2024
Last Update Submitted That Met QC Criteria
March 1, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RGC18100117
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tinnitus, Subjective
-
State University of New York at BuffaloUniversity at BuffaloCompletedTinnitus, Subjective | Tinnitus | Noise Induced Tinnitus | Tinnitus, Objective | Tinnitus Aggravated | Tinnitus, Pulsatile | Tinnitus, Spontaneous Oto-Acoustic Emission | Tinnitus, Clicking | Tinnitus, Tensor Tympani InducedUnited States
-
Philipps University Marburg Medical CenterLinkoeping University; Eriksholm Research Centre; University Hospital of Gießen...CompletedTinnitus | Subjective Tinnitus | Chronic TinnitusGermany
-
Otonomy, Inc.CompletedSubjective TinnitusUnited States, United Kingdom, Germany, Poland
-
Otonomy, Inc.Completed
-
Technical University of DenmarkCompleted
-
Cairo UniversityCompleted
-
Medical University of LodzCompleted
-
Pansatori GmbHCompetence Center for Medical Devices GmbHUnknown
-
Tel-Aviv Sourasky Medical CenterCompleted
-
Eye & ENT Hospital of Fudan UniversityUnknown
Clinical Trials on Amplification with hearing aid
-
Sonova AGThe State University of New York at BuffaloCompletedHearing Loss, Sensorineural | TinnitusUnited States
-
University of Sao Paulo General HospitalUnknownChronic TinnitusBrazil
-
University of Maryland, College ParkWithdrawnAuditory Perceptual Disorders | Age-related Hearing Loss
-
Seoul National University HospitalRecruitingHearing DisordersKorea, Republic of
-
Sonova AGCompleted
-
Sonova AGCompleted
-
Sonova AGCompletedHearing Loss | Normal HearingSwitzerland
-
Sonova AGCompleted
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Duke UniversityPatient-Centered Outcomes Research InstituteActive, not recruitingHearing LossUnited States